These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2752112)
1. Heparin binding to resting and activated platelets. Horne MK; Chao ES Blood; 1989 Jul; 74(1):238-43. PubMed ID: 2752112 [TBL] [Abstract][Full Text] [Related]
2. Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets. Brass LF; Shattil SJ J Clin Invest; 1984 Mar; 73(3):626-32. PubMed ID: 6231306 [TBL] [Abstract][Full Text] [Related]
3. Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Di Minno G; Thiagarajan P; Perussia B; Martinez J; Shapiro S; Trinchieri G; Murphy S Blood; 1983 Jan; 61(1):140-8. PubMed ID: 6216929 [TBL] [Abstract][Full Text] [Related]
4. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets. Boukerche H; McGregor JL Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471 [TBL] [Abstract][Full Text] [Related]
5. Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies. McEver RP; Bennett EM; Martin MN J Biol Chem; 1983 Apr; 258(8):5269-75. PubMed ID: 6220015 [TBL] [Abstract][Full Text] [Related]
6. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa. De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830 [TBL] [Abstract][Full Text] [Related]
7. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder. Hardisty R; Pidard D; Cox A; Nokes T; Legrand C; Bouillot C; Pannocchia A; Heilmann E; Hourdillé P; Bellucci S Blood; 1992 Aug; 80(3):696-708. PubMed ID: 1638023 [TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. McEver RP; Martin MN J Biol Chem; 1984 Aug; 259(15):9799-804. PubMed ID: 6746667 [TBL] [Abstract][Full Text] [Related]
9. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets. Parker RI; Gralnick HR Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923 [TBL] [Abstract][Full Text] [Related]
10. The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering. Isenberg WM; McEver RP; Phillips DR; Shuman MA; Bainton DF J Cell Biol; 1987 Jun; 104(6):1655-63. PubMed ID: 3584243 [TBL] [Abstract][Full Text] [Related]
11. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. Shattil SJ; Hoxie JA; Cunningham M; Brass LF J Biol Chem; 1985 Sep; 260(20):11107-14. PubMed ID: 2411729 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against porcine platelet membrane glycoproteins Ib and IIb/IIIa. Takami H; Nichols WL; Kaese SE; Miller RS; Katzmann JA; Bowie EJ Blood; 1988 Nov; 72(5):1740-7. PubMed ID: 3140912 [TBL] [Abstract][Full Text] [Related]
13. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody. Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325 [TBL] [Abstract][Full Text] [Related]
14. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247 [TBL] [Abstract][Full Text] [Related]
15. Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib. De Cristofaro R; De Candia E; Landolfi R; Rutella S; Hall SW Biochemistry; 2001 Nov; 40(44):13268-73. PubMed ID: 11683636 [TBL] [Abstract][Full Text] [Related]
16. Platelet integrin alpha IIb beta 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets. Pedreño J; Fernández R; Cullaré C; Barceló A; Elorza MA; de Castellarnau C Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):156-63. PubMed ID: 9012651 [TBL] [Abstract][Full Text] [Related]
17. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. Macfarlane DE; Srivastava PC; Mills DC J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277 [TBL] [Abstract][Full Text] [Related]
18. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function. Savage B; Marzec UM; Chao BH; Harker LA; Maraganore JM; Ruggeri ZM J Biol Chem; 1990 Jul; 265(20):11766-72. PubMed ID: 2365698 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor. Danton MC; Zaleski A; Nichols WL; Olson JD J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492 [TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease. Miller JL; Kupinski JM; Castella A; Ruggeri ZM J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]